當前位置：上海經(jīng)科化學科技有限公司>>抗體>>流式抗體>>Human CCL19 （MIP-3 beta） Recombinant Protein

Human CCL19 （MIP-3 beta） Recombinant Protein

返回列表頁

參考價

面議

具體成交價以合同協(xié)議為準

產品型號5 ug

品牌

廠商性質經(jīng)銷商

所在地上海市

在線詢價收藏產品查看聯(lián)系電話

聯(lián)系方式：李小姐查看聯(lián)系方式

更新時間：2017-08-11 03:46:20瀏覽次數(shù)：752次

聯(lián)系我時，請告知來自環(huán)保在線

產品分類 品牌分類

  抗體

流式抗體

全部產品列表

暫無信息

上海經(jīng)科化學科技有限公司

經(jīng)營模式：經(jīng)銷商

商鋪產品：183條

所在地區(qū)：上海上海市

聯(lián)系人：李小姐

詢價 給他留言

產品簡介

Human CCL19 (MIP-3 beta) Recombinant Protein
Also known as: C-C Motif Chemokine 19
RUO: For Research Use Only. Not for use in diagnostic procedures.

詳細介紹

Description: CCL19, also known as MIP-3 beta （Macrophage Inflammatory Protein 3 beta）, is a member of the CC- subfamily of chemokines. It is most closely related to CCL21, with which it shares 32% amino acid sequence homology. CCL19 and CCL21 are expressed mainly by stromal cells in the T cell-rich zones of lymph nodes. They are critical mediators of the homeostatic trafficking of naïve T cells and activated dendritic cells into the secondary lymphoid organs. CCL19 and CCL21 also play a role in T cell priming and activation, as well as the recruitment of lymphocytes to inflamed tissue. Both proteins signal via the G protein-coupled receptor, CCR7, which is expressed on T cells and mature dendritic cells. Although CCL19 and CCL21 both exhibit the same affinity for CCR7, only the binding of CCL19 results in the desensitization and internalization of the receptor.